论文部分内容阅读
本文比较小剂量阿糖胞甙(Ara-c)和强烈化疗对晚期骨髓增生异常综合征(MDS)的疗效。病人和方法 67例初诊的 MDS 病人,男34例,女33例。既往无化疗和放疗史。其中顽固性贫血(RA)4例,环状铁粒幼细胞性贫血(RARS)3例,伴幼稚细胞过多的顽固性贫血(RAEB)22例,转化
This article compares the efficacy of low-dose cytarabine (Ara-c) and intensive chemotherapy in patients with advanced myelodysplastic syndromes (MDS). Patients and Methods 67 cases of newly diagnosed MDS patients, 34 males and 33 females. Past history of chemotherapy and radiotherapy. Among them, 4 were refractory anemia (RA), 3 were RAGS, 22 were erythrocytic anemia (RAEB) with excessive naive cells,